Latest news
Glasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatment - EU-StartupsEU-Startups · Fri, 07 Aug 2026 12:14:34 GMTCAMP4 advances rare disease treatment for SYNGAP1 into human trials - CNBCCNBC · Thu, 06 Aug 2026 18:52:12 GMTZVRA: Revenue growth and strong liquidity support ongoing rare disease pipeline advancement - TradingViewTradingView · Wed, 05 Aug 2026 21:20:16 GMTScottish kidney disease biotech Mironid raises $46 million to advance rare disease pipeline - The Pharma LetterThe Pharma Letter · Wed, 05 Aug 2026 16:12:39 GMTMironid Secures $46m To Advance Rare Disease Therapeutics - eurekamagazine.co.ukeurekamagazine.co.uk · Wed, 05 Aug 2026 13:37:33 GMTIonic Rare Earths (ASX:IXR) Secures $8 Million Placement to Advance Rare Earth Commercialisation Strategy - KalkineKalkine · Wed, 05 Aug 2026 00:45:00 GMTJapan, US confirm rare joint yen-buying operation, open to further action (DXY:) - Seeking AlphaSeeking Alpha · Mon, 03 Aug 2026 04:30:08 GMTBrazil’s rare earths attract new investments with progress in projects and strategic partnerships - BNamericasBNamericas · Fri, 31 Jul 2026 12:01:06 GMT